Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 41Non-Muscle Invasive Bladder Neoplasms 25Colorectal Neoplasms 21Carcinoma, Transitional Cell 17Anus Neoplasms 17Neoplasm Metastasis 12Carcinoma, Hepatocellular 11Appendiceal Neoplasms 11Stomach Neoplasms 10Peritoneal Neoplasms 9Pancreatic Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Neoplasms 7Lung Neoplasms 6Colonic Neoplasms 6Rectal Neoplasms 5Liver Neoplasms 5Urologic Neoplasms 4Sarcoma 4Carcinoma 4Anal Canal Carcinoma 4Urologic Diseases 3Urogenital Neoplasms 3Urinary Bladder Diseases 3Recurrence 3Pseudomyxoma Peritonei 3Ovarian Neoplasms 3Neoplasms by Site 3Mesothelioma, Malignant 3Gastrointestinal Neoplasms 3

Interventions

Bacterial Load 2sodium thiosulfate 1nilotinib 1Paclitaxel 1Oxaliplatin 1Mitomycin 1Levetiracetam 1Fluorouracil 1Doxorubicin 1Conservative Treatment 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Necrosis × Mitomycin × Clear all
NCT04847063 2026-04-14

Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting
60 enrolled
GastrointestinalGynecologic

Appendiceal Neoplasms, Gastrointestinal Neoplasms, Necrosis, Ovarian Neoplasms, Peritoneal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡